Nagesh Ramesh: 80% of The World’s Population Lives in LMICs But They Collect Less Than 10% of The World’s Plasma
Nagesh Ramesh, President at Life Plasma, shared on LinkedIn:
”80% of the world’s population lives in low and middle income countries (LMICs) but they collect less than 10% of the world’s plasma.
Patients are deprived of life saving medicines and many countries are losing out on opportunities to create a whole new industry and job opportunities due to misinformation and virtue signalling by their governments.
I would like to thank Annals of Blood journal for publishing our paper on steps that LMIC governments can take to improve availability of life-saving plasma medicines.
Special thank you to my co-author David McIntosh for collaborating on this article and Jan Hartmann, for inviting me to write this article.”
Read the full article in Annals of Blood.
Article: How do we solve the shortage of plasma derived medicines in low- and middle-income countries (LMIC)?
Authors: Nagesh Ramesh, David McIntosh

Stay updated on all scientific advances with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis
